Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China · Delayed Price · Currency is CNY 25.74
-0.21 (-0.81%)
Sep 10, 2026, 11:28 AM CST
SHA:688566 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,001 | 966.07 | 896.53 | 860.93 | 654.73 | 509.69 |
Revenue Growth | 9.03% | 7.76% | 4.13% | 31.49% | 28.46% | -9.94% |
Gross Profit Gross Profit Growth | 896.76 | 864.25 | 801.28 | 763.76 | 578.56 | 447.57 |
Operating Income Operating Income Growth | 240.26 | 249.58 | 292.06 | 230.44 | 151.85 | 106.32 |
Net Income Net Income Growth | 211.53 | 261.61 | 219.33 | 219.09 | 154.67 | 114.9 |
Earnings Per Share EPS Growth | 1.06 | 1.31 | 1.13 | 1.17 | 0.83 | 0.61 |
EPS Growth | -14.06% | 15.93% | -3.42% | 40.96% | 36.07% | -20.78% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 869.27 | 849.51 | 903.52 | 729.87 | 993.9 | 1,225 |
Total Debt Total Debt Growth | 12.32 | 18.72 | 20.83 | 9.91 | - | - |
Net Cash (Debt) Net Cash Growth | 856.95 | 830.79 | 882.69 | 719.96 | 993.9 | 1,225 |
Net Cash Growth | -6.57% | -5.88% | 22.60% | -27.56% | -18.87% | -4.84% |
Net Cash Per Share Net Cash Per Share Growth | 4.30 | 4.16 | 4.55 | 3.84 | 5.33 | 6.50 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 224.49 | 248.3 | 215.29 | 159.5 | 150.72 | 150.56 |
Capital Expenditures CapEx Growth | -87.4 | -114.6 | -174.53 | -357.37 | -292.7 | -83.79 |
Free Cash Flow Free Cash Flow Growth | 137.09 | 133.71 | 40.76 | -197.87 | -141.98 | 66.77 |
Free Cash Flow Growth | 44.43% | 228.01% | - | - | - | -28.73% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 89.61% | 89.46% | 89.38% | 88.71% | 88.37% | 87.81% |
Operating Margin | 24.01% | 25.84% | 32.58% | 26.77% | 23.19% | 20.86% |
Pretax Margin | 24.23% | 31.17% | 28.26% | 28.75% | 26.66% | 26.01% |
Profit Margin | 21.14% | 27.08% | 24.46% | 25.45% | 23.62% | 22.54% |
FCF Margin | 13.70% | 13.84% | 4.55% | -22.98% | -21.68% | 13.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.520 | 0.520 | 0.780 | - | 0.480 | 0.480 |
Dividend Per Share Growth | -50.00% | -33.33% | - | - | 0% | 0% |
Dividend Yield | 2.03% | 1.76% | 3.57% | - | 2.37% | 2.28% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.46 | 22.76 | 20.37 | 27.09 | 25.89 | 37.13 |
Forward PE | - | 15.51 | 13.50 | 25.42 | 24.76 | - |
P/FCF Ratio | 38.07 | 44.52 | 109.59 | - | - | 63.89 |
PS Ratio | 5.21 | 6.16 | 4.98 | 6.89 | 6.12 | 8.37 |